2009
DOI: 10.1038/cr.2009.99
|View full text |Cite
|
Sign up to set email alerts
|

Bystin-like protein is upregulated in hepatocellular carcinoma and required for nucleologenesis in cancer cell proliferation

Abstract: The bystin-like (BYSL) gene was previously characterized to encode an accessory protein for cell adhesion that participates in early embryo implantation. It is also involved in 40S ribosomal subunit biogenesis and is found to be expressed in rapidly growing embryo and cancer cell lines. In order to explore the role of BYSL in cancer cell proliferation and growth, we used hepatocellular carcinoma (HCC) as a model. Here, we report that BYSL is crucial for HCC cell growth both in vitro and in vivo. Expression lev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
41
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(41 citation statements)
references
References 46 publications
0
41
0
Order By: Relevance
“…The dysregulation of ribosome biogenesis has shown to be associated with tumor progression of breast adenocarcinoma MCF-7 cell line [27]. The ribosome assembly factor bystin is overexpressed in hepatocellular carcinoma and is required for cell growth and tumor development [28,29]. These findings suggest that WBSCR22 should be investigated further as potential therapeutic target in cancer cells.…”
Section: Discussionmentioning
confidence: 99%
“…The dysregulation of ribosome biogenesis has shown to be associated with tumor progression of breast adenocarcinoma MCF-7 cell line [27]. The ribosome assembly factor bystin is overexpressed in hepatocellular carcinoma and is required for cell growth and tumor development [28,29]. These findings suggest that WBSCR22 should be investigated further as potential therapeutic target in cancer cells.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, the genelist already provides some interesting genes as candidate oncogenes whose oncogenic potential has been demonstrated in other tumor types. The genes include NOTCH1 [34], [35], [36], BMI1 [37], [38], [39], [40], [41], EFNA1 [42], [43], NCOA2 [44], BYSL [45], [46], and RAD21 [47]. For example, Notch1, a member of Notch family receptor has been indicated as an oncogene in multiple tumor types.…”
Section: Discussionmentioning
confidence: 99%
“…For example, increased ribosome biogenesis caused by depletion of the cell-cycle control protein ADP ribosylation factor like 2 (Arl-2) also showed increases in nucleolar number, nucleolar area, and aggressivity of the tumor (Belin et al 2009). In addition, bystin-like (BYSL), a protein involved in pre-18S rRNA processing, may play a role in driving tumor formation as its inhibition has been shown to prevent tumor formation in nude mice (Wang et al 2009). Another way of examining how the nucleolus drives cancer is through ribosomopathies.…”
Section: Cancer and The Nucleolusmentioning
confidence: 99%